Home Applications 013025 Application 013025
Type NDA
Sponsor HOSPIRA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 THAM-E POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE INJECTABLE;INJECTION 370MG/VIAL;1.75GM/VIAL;36GM/VIAL No No 002 THAM TROMETHAMINE INJECTABLE;INJECTION 3.6GM/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N013025-001 THAM-E POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE 370MG/VIAL;1.75GM/VIAL;36GM/VIAL INJECTABLE / INJECTION Approved before 1982 N013025-002 THAM TROMETHAMINE 18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INJECTION AP RLD, RS, Approved before 1982
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N013025-002 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 3 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N013025-001 THAM-E 370MG/VIAL;1.75GM/VIAL;36GM/VIAL INJECTABLE / INJECTION Approved before 1982 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N013025-002 THAM 18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INJECTION RLD, RS, Approved before 1982 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N013025-001 THAM-E 370MG/VIAL;1.75GM/VIAL;36GM/VIAL INJECTABLE / INJECTION Approved before 1982 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N013025-002 THAM 18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INJECTION RLD, RS, Approved before 1982 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N013025-001 THAM-E 370MG/VIAL;1.75GM/VIAL;36GM/VIAL INJECTABLE / INJECTION Approved before 1982 e64feba35796…2022-09-29 23:25 UTC 2022-09 N013025-002 THAM 18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INJECTION RLD, RS, Approved before 1982 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N013025-001 THAM-E 370MG/VIAL;1.75GM/VIAL;36GM/VIAL INJECTABLE / INJECTION Approved before 1982 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N013025-002 THAM 18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INJECTION RLD, RS, Approved before 1982 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N013025-001 THAM-E 370MG/VIAL;1.75GM/VIAL;36GM/VIAL INJECTABLE / INJECTION Approved before 1982 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N013025-002 THAM 18GM/500ML (3.6GM/100ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INJECTION AP RLD, RS, Approved before 1982 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 1 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0409-1593 THAM TROMETHAMINE Hospira, Inc. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 350 SUPPL 2006-07-21 33099 SUPPL 2006-07-20